DrugDashboards

Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide

Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide · OLMESARTAN MEDOXOMIL 40 mg/1; AMLODIPINE BESYLATE 10 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 · Tablet, Film Coated · Oral · Teva Pharmaceuticals USA, Inc.

NDC 00093-5002-56 · 30 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 22% over the past year, to $1.03 per unit. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$1.03per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Federal contracts pay (FSS)$0.6280per unitAvKare, LLC · Jun 15, 202361% of what pharmacies pay — a deeper discount than 81% of drugs with this benchmark
  • Medicaid generic ceiling (FUL)$1.06per TABweighted avg manufacturer price $0.6080 · Aug 1, 2026103% of what pharmacies pay — higher than 57% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$2.00$4.00Jan 2017Sep 2026$1.03
117 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$31.02
#90 count
$93.07

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$201,170
2,873 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

28● Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 2 active manufacturers+20
  • price down 22% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for olmesartan medoxomil, amlodipine and hydrochlorothiazide (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA202491
TE code
AB
Approval date
Nov 3, 2016
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Camber Pharmaceuticals, Inc.OLMESARTAN MEDOXOMIL 20 mg/1; AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.OLMESARTAN MEDOXOMIL 40 mg/1; AMLODIPINE BESYLATE 10 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.OLMESARTAN MEDOXOMIL 40 mg/1; AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1Aug 26, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.OLMESARTAN MEDOXOMIL 40 mg/1; AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.OLMESARTAN MEDOXOMIL 40 mg/1; AMLODIPINE BESYLATE 10 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1Aug 26, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.OLMESARTAN MEDOXOMIL 40 mg/1; AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.OLMESARTAN MEDOXOMIL 40 mg/1; AMLODIPINE BESYLATE 10 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1Aug 26, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.OLMESARTAN MEDOXOMIL 40 mg/1; AMLODIPINE BESYLATE 10 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.OLMESARTAN MEDOXOMIL 20 mg/1; AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.OLMESARTAN MEDOXOMIL 40 mg/1; AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1Aug 26, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.OLMESARTAN MEDOXOMIL 10 mg/1; AMLODIPINE BESYLATE 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1Jul 22, 2026Aug 19, 2026
Camber Pharmaceuticals, Inc.OLMESARTAN MEDOXOMIL 5 mg/1; AMLODIPINE BESYLATE 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1Jul 22, 2026Aug 19, 2026
Camber Pharmaceuticals, Inc.OLMESARTAN MEDOXOMIL 10 mg/1; AMLODIPINE BESYLATE 25 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1Jul 22, 2026Aug 19, 2026
Camber Pharmaceuticals, Inc.OLMESARTAN MEDOXOMIL 5 mg/1; AMLODIPINE BESYLATE 25 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1Jul 22, 2026Aug 19, 2026
Camber Pharmaceuticals, Inc.OLMESARTAN MEDOXOMIL 5 mg/1; AMLODIPINE BESYLATE 12.5 mg/1; HYDROCHLOROTHIAZIDE 20 mg/1Jul 22, 2026Aug 19, 2026
Teva Pharmaceuticals USA, Inc.OLMESARTAN MEDOXOMIL 5 mg/1; AMLODIPINE BESYLATE 25 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1Jul 22, 2026Aug 19, 2026
Teva Pharmaceuticals USA, Inc.OLMESARTAN MEDOXOMIL 10 mg/1; AMLODIPINE BESYLATE 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1Jul 22, 2026Aug 19, 2026
Teva Pharmaceuticals USA, Inc.OLMESARTAN MEDOXOMIL 10 mg/1; AMLODIPINE BESYLATE 25 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1Jul 22, 2026Aug 19, 2026
Teva Pharmaceuticals USA, Inc.OLMESARTAN MEDOXOMIL 5 mg/1; AMLODIPINE BESYLATE 12.5 mg/1; HYDROCHLOROTHIAZIDE 20 mg/1Jul 22, 2026Aug 19, 2026
Teva Pharmaceuticals USA, Inc.OLMESARTAN MEDOXOMIL 5 mg/1; AMLODIPINE BESYLATE 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1Jul 22, 2026Aug 19, 2026
Camber Pharmaceuticals, Inc.AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1; OLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Jul 15, 2026
Camber Pharmaceuticals, Inc.AMLODIPINE BESYLATE 10 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Jul 15, 2026
Camber Pharmaceuticals, Inc.AMLODIPINE BESYLATE 10 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Jul 15, 2026
Camber Pharmaceuticals, Inc.AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Jul 15, 2026
Camber Pharmaceuticals, Inc.AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Jul 15, 2026
Teva Pharmaceuticals USA, Inc.AMLODIPINE BESYLATE 10 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Jul 15, 2026
Teva Pharmaceuticals USA, Inc.AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1; OLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Jul 15, 2026
Teva Pharmaceuticals USA, Inc.AMLODIPINE BESYLATE 10 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Jul 15, 2026
Teva Pharmaceuticals USA, Inc.AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Jul 15, 2026
Teva Pharmaceuticals USA, Inc.AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide — NDC 00093-5002-56," retrieved September 3, 2026, https://drugdashboards.com/drug/00093500256.

Free to cite with attribution — see how the data is put together.